West Pharmaceutical Services, Inc. Stock
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:00:02 2026-10-02 pm EDT
|
5-day change | 1st Jan Change | ||
| 364.98 USD | -0.01% |
|
-1.47% | +32.65% |
| Sep. 23 | US companies face rise in cyber attacks | RE |
| Sep. 22 | West Pharmaceutical Poised to See EPS Upside to Current 2027 Wall Street Estimates, Morgan Stanley Says | MT |
| Market Cap | 25.69B 22.83B 21.28B 19.4B 36.59B 2,474B 36.94B 258B 99.97B 1,261B 96.43B 94.34B 4,054B | P/E 2026 * |
42.6x | P/E 2027 * | 37x |
|---|---|---|---|---|---|
| Enterprise Value | 25.18B 22.38B 20.86B 19.02B 35.88B 2,425B 36.22B 253B 98.02B 1,237B 94.54B 92.49B 3,975B | EV / Sales 2026 * |
7.46x | EV / Sales 2027 * | 6.89x |
| Free-Float |
92.88% | Yield 2026 * |
0.25% | Yield 2027 * | 0.27% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| WST | Delayed | |
CBOE
| WST | Real-time | |
|
London S.E.
| 0ADY | Delayed | |
|
Tradegate
| WPS | Real-time | |
|
Deutsche Boerse AG
| WPS | Delayed | |
|
Börse Stuttgart
| WPS | Delayed | |
|
Boerse Muenchen
| WPS | Real-time | |
|
Berne S.E.
| WPS | End-of-day quote | |
|
Borsa Italiana
| 1WST | End-of-day quote |
Last Transcript: West Pharmaceutical Services, Inc.
| Aug. 26 | West to Participate in Upcoming Investor Conferences | PR |
| Jul. 23 | West Pharmaceutical: Q2 Earnings Snapshot | AQ |
| Jul. 23 | West Reports Second-Quarter 2026 Results | PR |
| Jul. 21 | West Declares Quarterly Dividend | PR |
| Jul. 07 | West to Host Second-Quarter 2026 Conference Call | PR |
| 1 day | -0.01% | ||
| 1 week | -1.47% | ||
| Current month | -1.56% | ||
| 1 month | +6.52% | ||
| 3 months | -0.21% | ||
| 6 months | +43.24% | ||
| Current year | +32.65% |
| 1 week | 363.12 |  | 378.47 |
| 1 month | 331.99 | | 382.71 |
| Current year | 223.83 | | 386 |
| 1 year | 223.83 | | 386 |
| 3 years | 187.43 | | 413.7 |
| 5 years | 187.43 | | 475 |
| 10 years | 70.17 | | 475.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michel Lagarde
CEO | Chief Executive Officer | 52 | 2026-08-30 |
Robert McMahon
DFI | Director of Finance/CFO | 57 | 2025-08-03 |
Devesh Mathur
CTO | Chief Tech/Sci/R&D Officer | - | 2025-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Buthman
BRD | Director/Board Member | 65 | 2011-01-31 |
Douglas Michels
BRD | Director/Board Member | 69 | 2011-03-06 |
William Feehery
BRD | Director/Board Member | 56 | 2012-02-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/15/26 | Exercice | Head of Human Resources | 7,572 | 0.0108% | ||
| 9/8/26 | Free | Chief Executive Officer | 51,798 | 0.0736% | ||
| 9/8/26 | Exercice | Head of Human Resources | 24,405 | 0.0347% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.01% | -1.47% | +33.61% | -1.51% | 25.69B | |
| +0.84% | -3.74% | -26.69% | +1.85% | 169B | |
| -0.07% | -2.55% | -9.53% | +11.07% | 110B | |
| +0.90% | +1.13% | -24.83% | +0.58% | 106B | |
| -1.24% | -0.76% | -49.04% | -12.75% | 73.87B | |
| -0.24% | +0.69% | +0.16% | +72.58% | 58.98B | |
| -0.86% | +2.96% | +13.57% | +59.50% | 51.28B | |
| -0.71% | -3.82% | -7.72% | -31.41% | 48.16B | |
| +0.12% | -0.17% | -18.21% | +20.29% | 40.84B | |
| -1.01% | -1.45% | +28.48% | -9.72% | 32.21B | |
| Average | -0.23% | -1.00% | -6.02% | +11.05% | 71.59B | |
| Weighted average by Cap. | +0.02% | -1.33% | -14.57% | +9.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.38B 3B 2.8B 2.55B 4.81B 325B 4.85B 33.89B 13.14B 166B 12.67B 12.4B 533B | 3.59B 3.19B 2.97B 2.71B 5.11B 345B 5.16B 36.02B 13.96B 176B 13.47B 13.17B 566B |
| Net income | 621M 552M 515M 469M 885M 59.85B 894M 6.24B 2.42B 30.52B 2.33B 2.28B 98.09B | 710M 631M 588M 536M 1.01B 68.39B 1.02B 7.13B 2.76B 34.88B 2.67B 2.61B 112B |
| Net Debt | -503M -447M -417M -380M -717M -48.46B -724M -5.05B -1.96B -24.71B -1.89B -1.85B -79.43B | -973M -865M -807M -735M -1.39B -93.75B -1.4B -9.78B -3.79B -47.81B -3.65B -3.58B -154B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | $364.98 | -0.01% | 473,016 |
| 26-10-01 | $365.01 | -1.55% | 670,874 |
| 26-09-30 | $370.76 | -1.56% | 471,176 |
| 26-09-29 | $376.63 | +0.26% | 560,122 |
| 26-09-28 | $375.65 | +1.41% | 567,555 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WST Stock
Select your edition
All financial news and data tailored to specific country editions
